Skip to main content

Table 2 COVID-19 survey participants baseline characteristics (n = 50), 2018–2021

From: Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis

 

n (%)

Demographics

 

Age (mean, SD)

40.4 (SD 10.0)

Gender

 

 Male

26 (52.0%)

 Female

24 (48.0%)

Race/Ethnicity

 

 White

44 (88.0%)

 Black

5 (10.0%)

 American Indian/Alaska Native

1 (2.0%)

 Latino/Hispanic

0 (0.0%)

Education

 

 Elementary

7 (14.0)

 Some high school

21 (42.0)

 High school graduate

16 (32.0)

 Some college/technical

5 (10.0)

 Missing

1 (2.0)

Homeless (last 6 months)

31 (62.0%)

Accessed Food Supports (last 6 months)

46 (92.0%)

Overdose questions

 

 Ever experienced an overdose

27 (54.0%)

 Lifetime number of overdose(s) experienced (mean, SD)

3.5 (SD 6.1)

 Lifetime number of overdose(s) experienced [median, IQR]

2 [1, 3]

 Witnessed an overdose

38 (76.0%)

 Have you ever been trained to recognize and respond to an overdose?

24 (48.0%)

 Have you ever called 911 because someone overdosed?

23 (46.0%)

 Have you ever gotten an overdose reversal kit or prescription for naloxone or Narcan?

25 (50.0%)

 Have you ever used naloxone or Narcan on someone to reverse an overdose?* (n = 39)

19 (48.7%)

 Do you currently have naloxone or Narcan with you or at home?* (n = 39)

26 (66.7%)

 How many people you know have died from an overdose in the past 6 months?

2.1 (SD 3.0)

  1. *Not all 50 participants were asked this question given a branching logic for participants enrolled in the UG3 study